Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Antiviral response ‐ 2mg/Kg · patients being treated for HIV infection

It is very uncertain whether PRO 140 changes antiviral response: 2 mg/kg compared with placebo (very low certainty).

1 finding from 1 review

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
OR 27.44 [1.25, 601.57]
1 study · 19 participants
Very low

Antiviral response ‐ 5mg/Kg · patients being treated for HIV infection

It is very uncertain whether PRO 140 changes antiviral response: 5 mg/kg compared with placebo (very low certainty).

1 finding from 1 review

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
OR 439.09 [25.73, 7493.14]
2 studies · 40 participants
Very low

Antiviral response: 10 mg/kg · patients being treated for HIV infection

It is very uncertain whether PRO 140 changes antiviral response: 10 mg/kg compared with placebo (very low certainty).

1 finding from 1 review

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
OR 145.67 [5.3, 4004.91]
1 study · 21 participants
Very low

Antiviral response ‐ 0.5mg/Kg · patients being treated for HIV infection

It is very uncertain whether PRO 140 changes antiviral response: 0.5 mg/kg compared with placebo (very low certainty).

1 finding from 1 review

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection 2014 · Cochrane Headline outcomes only
OR 3 [0.11, 83.36]
1 study · 19 participants
Very low